• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞巴派特滴眼液调节干燥性眼病模型小鼠中辅助性 T 细胞 17/调节性 T 细胞的比例。

Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice.

机构信息

Department of Ophthalmology, The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning 110032, P.R. China.

Department of Ophthalmology, Shenyang Fourth People's Hospital, Shenyang, Liaoning 110031, P.R. China.

出版信息

Mol Med Rep. 2019 May;19(5):4011-4018. doi: 10.3892/mmr.2019.10068. Epub 2019 Mar 21.

DOI:10.3892/mmr.2019.10068
PMID:30896815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6472194/
Abstract

The aim of the present study was to confirm the effect of 2% rebamipide ophthalmic solution on a scopolamine‑induced dry eye (DE) mouse model, and to investigate its effect on the ratio of T helper cell 17 (Th17)/regulatory T cell (Treg) numbers. C57BL/6 mice received subcutaneous injections of scopolamine and were exposed to a low‑humidity environment in order to establish a DE model. Rebamipide eye drops (2%) administered four times daily for 2 weeks, significantly reduced the corneal staining scores and increased the tear film breakup time and tear production in the DE mice. Pathologically, the rebamipide restored the histological changes induced by DE in the cornea, conjunctiva and lacrimal gland. At a molecular level, it downregulated pro‑inflammatory and upregulated anti‑inflammatory cytokines in the conjunctiva and lacrimal gland. Furthermore, the increased Th17 and Treg levels were restored following treatment with rebamipide. In conclusion, the anti‑inflammatory and Th17/Treg balance‑preserving effects of rebamipide may contribute to the treatment of DE in mice.

摘要

本研究旨在证实 2%瑞巴派特滴眼液对东莨菪碱诱导的干眼症(DE)小鼠模型的作用,并研究其对辅助性 T 细胞 17(Th17)/调节性 T 细胞(Treg)比值的影响。C57BL/6 小鼠接受东莨菪碱皮下注射,并暴露于低湿度环境中以建立 DE 模型。瑞巴派特滴眼液(2%)每日滴眼 4 次,连续 2 周,可显著降低角膜染色评分,并增加 DE 小鼠的泪膜破裂时间和泪液分泌。在病理上,瑞巴派特恢复了 DE 引起的角膜、结膜和泪腺的组织学变化。在分子水平上,它下调了结膜和泪腺中的促炎细胞因子,上调了抗炎细胞因子。此外,瑞巴派特治疗后可恢复升高的 Th17 和 Treg 水平。总之,瑞巴派特的抗炎和 Th17/Treg 平衡维持作用可能有助于治疗小鼠的 DE。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/3e9ca8d05026/MMR-19-05-4011-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/7f2cc83f36d8/MMR-19-05-4011-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/3dfa8fe79a11/MMR-19-05-4011-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/047131d95e9d/MMR-19-05-4011-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/270f4ca288bf/MMR-19-05-4011-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/3e9ca8d05026/MMR-19-05-4011-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/7f2cc83f36d8/MMR-19-05-4011-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/3dfa8fe79a11/MMR-19-05-4011-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/047131d95e9d/MMR-19-05-4011-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/270f4ca288bf/MMR-19-05-4011-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a9fe/6472194/3e9ca8d05026/MMR-19-05-4011-g04.jpg

相似文献

1
Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice.瑞巴派特滴眼液调节干燥性眼病模型小鼠中辅助性 T 细胞 17/调节性 T 细胞的比例。
Mol Med Rep. 2019 May;19(5):4011-4018. doi: 10.3892/mmr.2019.10068. Epub 2019 Mar 21.
2
The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.2%瑞巴派特滴眼液在超氧化物歧化酶 1(Sod1)基因敲除小鼠结膜分化中的作用。
Invest Ophthalmol Vis Sci. 2018 Mar 1;59(3):1675-1681. doi: 10.1167/iovs.17-23213.
3
Rebamipide suppresses collagen-induced arthritis through reciprocal regulation of th17/treg cell differentiation and heme oxygenase 1 induction.雷贝拉唑通过调节 Th17/Treg 细胞分化和诱导血红素加氧酶 1 抑制胶原诱导性关节炎。
Arthritis Rheumatol. 2014 Apr;66(4):874-85. doi: 10.1002/art.38310.
4
The Effects of Rebamipide 2% Ophthalmic Solution Application on Murine Subbasal Corneal Nerves After Environmental Dry Eye Stress.环境干燥眼应激后, 2%瑞巴派特滴眼液对小鼠角膜基底神经的影响。
Int J Mol Sci. 2019 Aug 18;20(16):4031. doi: 10.3390/ijms20164031.
5
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.2%瑞巴派特滴眼液对超氧化物歧化酶-1(SOD1)基因敲除小鼠泪液功能和眼表的影响。
Invest Ophthalmol Vis Sci. 2013 Nov 21;54(12):7793-802. doi: 10.1167/iovs.13-13128.
6
Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.瑞巴派特通过相互调节κ-卡拉胶诱导的脊柱关节炎小鼠的Th17/Treg细胞失衡来预防外周关节炎和肠道炎症。
J Transl Med. 2016 Jun 27;14(1):190. doi: 10.1186/s12967-016-0942-5.
7
A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.一项比较 2%瑞巴派特(OPC-12759)与 0.1%玻璃酸钠治疗干眼症的随机、多中心 3 期研究。
Ophthalmology. 2013 Jun;120(6):1158-65. doi: 10.1016/j.ophtha.2012.12.022. Epub 2013 Mar 13.
8
Efficacy of Rebamipide Instillation for Contact Lens Discomfort With Dry Eye.瑞巴派特滴眼液治疗隐形眼镜相关性干眼不适的疗效
Eye Contact Lens. 2018 Nov;44 Suppl 2(2):S137-S142. doi: 10.1097/ICL.0000000000000438.
9
Cevimeline-induced anti-inflammatory effect through upregulations of mucins in the ocular surface of a dry eye mouse model.西维美林通过上调干眼模型小鼠眼表面黏蛋白发挥抗炎作用。
Biomed Pharmacother. 2021 Jul;139:111571. doi: 10.1016/j.biopha.2021.111571. Epub 2021 Apr 13.
10
Effects of silk fibroin in murine dry eye.丝素蛋白对小鼠干眼症的影响。
Sci Rep. 2017 Mar 10;7:44364. doi: 10.1038/srep44364.

引用本文的文献

1
Rebamipide Enhances Pathogen Defense and Mitigates Inflammation in a Particulate Matter-Induced Ocular Surface Inflammation Rat Model.瑞巴派特增强病原体防御并减轻颗粒物诱导的眼表炎症大鼠模型中的炎症反应。
Int J Mol Sci. 2025 Apr 21;26(8):3922. doi: 10.3390/ijms26083922.
2
Endoplasmic Reticulum Stress Induces ROS Production and Activates NLRP3 Inflammasome Via the PERK-CHOP Signaling Pathway in Dry Eye Disease.内质网应激通过PERK-CHOP信号通路诱导活性氧生成并激活干眼疾病中的NLRP3炎性小体。
Invest Ophthalmol Vis Sci. 2024 Dec 2;65(14):34. doi: 10.1167/iovs.65.14.34.
3
High-Performance Liquid Chromatography (HPLC) Method Validation for Identifying and Quantifying Rebamipide in Ethosomes.

本文引用的文献

1
Lacrimal gland development: From signaling interactions to regenerative medicine.泪腺发育:从信号相互作用到再生医学。
Dev Dyn. 2017 Dec;246(12):970-980. doi: 10.1002/dvdy.24551. Epub 2017 Aug 18.
2
Conjunctival Goblet Cell Density Following Cataract Surgery With Diclofenac Versus Diclofenac and Rebamipide: A Randomized Trial.双氯芬酸与双氯芬酸联合瑞巴派特用于白内障手术后结膜杯状细胞密度的比较:一项随机试验
Am J Ophthalmol. 2017 Sep;181:26-36. doi: 10.1016/j.ajo.2017.06.016. Epub 2017 Jun 29.
3
Rebamipide prevents peripheral arthritis and intestinal inflammation by reciprocally regulating Th17/Treg cell imbalance in mice with curdlan-induced spondyloarthritis.
用于鉴定和定量脂质体中瑞巴派特的高效液相色谱(HPLC)方法验证
Cureus. 2024 Mar 12;16(3):e56061. doi: 10.7759/cureus.56061. eCollection 2024 Mar.
4
Effect of Topical Programmed Death-Ligand1 on Corneal Epithelium in Dry Eye Mouse.靶向程序性死亡配体 1 对干燥性角膜结膜炎模型小鼠角膜上皮的影响。
Biomolecules. 2024 Jan 4;14(1):68. doi: 10.3390/biom14010068.
5
Ocular surface immune cell diversity in dry eye disease.干眼疾病中眼表面免疫细胞的多样性。
Indian J Ophthalmol. 2023 Apr;71(4):1237-1247. doi: 10.4103/IJO.IJO_2986_22.
6
Therapeutic Potential of d-MAPPS™ for Ocular Inflammatory Diseases and Regeneration of Injured Corneal and Retinal Tissue.d-MAPPS™ 在眼部炎症性疾病和受损角膜及视网膜组织再生中的治疗潜力。
Int J Mol Sci. 2022 Nov 4;23(21):13528. doi: 10.3390/ijms232113528.
7
Thermogels containing sulfated hyaluronan as novel topical therapeutics for treatment of ocular surface inflammation.含有硫酸化透明质酸的热凝胶作为治疗眼表炎症的新型局部治疗药物。
Mater Today Bio. 2021 Dec 3;13:100183. doi: 10.1016/j.mtbio.2021.100183. eCollection 2022 Jan.
8
The role of Th17 immunity in chronic ocular surface disorders.Th17 免疫在慢性眼表面疾病中的作用。
Ocul Surf. 2021 Jan;19:157-168. doi: 10.1016/j.jtos.2020.05.009. Epub 2020 May 26.
瑞巴派特通过相互调节κ-卡拉胶诱导的脊柱关节炎小鼠的Th17/Treg细胞失衡来预防外周关节炎和肠道炎症。
J Transl Med. 2016 Jun 27;14(1):190. doi: 10.1186/s12967-016-0942-5.
4
The Effect of the Aqueous Extract of Bidens Pilosa L. on Androgen Deficiency Dry Eye in Rats.鬼针草水提取物对大鼠雄激素缺乏性干眼的影响。
Cell Physiol Biochem. 2016;39(1):266-77. doi: 10.1159/000445622. Epub 2016 Jun 24.
5
A Comprehensive Review of Sex Disparities in Symptoms, Pathophysiology, and Epidemiology of Dry Eye Syndrome.干眼综合征症状、病理生理学和流行病学中性别差异的综合综述
Semin Ophthalmol. 2016;31(4):325-36. doi: 10.3109/08820538.2016.1154168. Epub 2016 Apr 21.
6
Treatment of Dry Eye Disease.干眼症的治疗
Consult Pharm. 2016 Feb;31(2):96-106. doi: 10.4140/TCP.n.2016.96.
7
Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.两例免疫性干眼症患者使用瑞巴派特和地夸磷索的长期疗效观察
Optom Vis Sci. 2015 Apr;92(4 Suppl 1):S25-32. doi: 10.1097/OPX.0000000000000523.
8
Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions.瑞巴派特眼用混悬液对伴有或不伴有泪点阻塞的干燥综合征患者干眼的体征和症状的影响。
Cornea. 2014 Aug;33(8):806-11. doi: 10.1097/ICO.0000000000000155.
9
Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.贝那普肽滴眼剂对原发性干燥综合征小鼠模型眼部病变的抗炎作用。
PLoS One. 2014 May 27;9(5):e98390. doi: 10.1371/journal.pone.0098390. eCollection 2014.
10
A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.一项多中心、开放标签、为期 52 周的研究,评估 2%瑞巴派特(OPC-12759)滴眼液治疗干眼症患者的疗效。
Am J Ophthalmol. 2014 Mar;157(3):576-83.e1. doi: 10.1016/j.ajo.2013.11.010. Epub 2013 Nov 16.